Facility Evaluation Report

Licensing Program Analyst (LPA) Cuadra arrived unannounced to conduct a Case Management Inspection and met with House Manager Ed Lara. LPA conducted risk assessment with House Manager at facility entrance. LPA arrived at the facility and had her temperature checked and was logged into a sign-in sheet.

During today's visit LPA is following up on an incident report received at CCL on 3/14/22 involving Client (C1). On 3/13/22 at around 3:05pm House Manager noticed on the bubble pack that the Mirtazapine 45mg tablet was still there for the day before 3/12/22 that was supposed to be provided to C1. House Manager inquired with staff who stated that all clients were provided with their medications as prescribed by their Physicians. However, there was no reason why C1 missed a dosage o f their prescribed medication. After the incident, house manager notified the Administrator and responsible party. Per house manager, C1's Physician was not contacted because 24 hours after the missed dosage has already passed and no reactions were observed by staff. During today’s visit LPA was informed that the facility will review medication again and will schedule medication training to remind staff to follow physician’s directions and assist clients with their medications as prescribed. House manager agreed to submit records of training that will be conducted with all staff.

Deficiencies cited from the California Code of Regulations, Title 22, Division 6 of California Regulation. Appeal rights given. Failure to correct the deficiency and/or repeat deficiencies within a 12-month period may result in civil penalties.